You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 102 No. 10, October 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIALS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Management of Choroidal Melanoma

Samuel Packer, MD

Arch Ophthalmol. 1984;102(10):1450-1452.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

There are many unanswered questions regarding the correct treatment of malignant melanoma of the choroid. The complexity of cancer is well recognized. Some feel chimera (an animalistic monster) would be a more appropriate term. But the problem for ophthalmology may lie in the Ptolemaic view that has prevented us from seeing the disease beyond the eye.

See also p 1477.

This editorial does not address the following important questions: Is enucleation associated with an increased likelihood of metastatic seeding? Is radiation therapy a more effective treatment than enucleation? Which form of radiation therapy is most effective? Should adjuvant chemotherapy be used with enucleation or with radiation therapy? It does address the questions that arise when one considers hyperthermia as a treatment modality for choroidal melanoma. Furthermore, the discussion pertains only to the local treatment of a malignant neoplasm known to have a substantial mortality associated with metastasis. Whether a malignant . . . [Full Text PDF of this Article]


Author Affiliations

Manhasset, NY



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.